Herbal Medicines for the Treatment of Chronic Obstructive Airway Diseases (Asthma or Chronic Obstructive Pulmonary Disease): A Prospective Observational Study
Table 7
SGRQ before and after herbal medicine treatments.
Total (n = 24)
Asthma (n = 14)
COPD (n = 10)
Symptom
Baseline
62.91 (55.81, 70.00)
70.73 (63.52, 77.93)
51.95 (40.25, 63.66)
Week 12
56.26 (47.36, 65.17)
63.38 (51.24, 75.53)
46.30 (35.50, 57.09)
value
0.0732
0.1527
0.3084
Activity
Baseline
47.41 (38.54, 56.28)
44.14 (34.40, 53.89)
51.99 (33.37, 70.60)
Week 12
45.35 (33.78, 56.92)
47.06 (30.98, 63.15)
42.95 (26.46, 59.44)
value
0.6796
0.6514
0.2153
Impact
Baseline
30.66 (23.20, 38.13)
34.94 (25.12, 44.77)
24.67 (12.04, 37.30)
Week 12
27.00 (19.02, 34.98)
34.50 (23.71, 45.28)
16.51 (6.88, 26.14)
value
0.1066
0.8903
0.0147
Total
Baseline
46.99 (40.77, 53.22)
49.94 (41.97, 57.91)
42.87 (31.62, 54.12)
Week 12
42.87 (34.76, 50.98)
48.32 (37.01, 59.62)
35.25 (25.23, 45.26)
value
0.1190
0.6574
0.0265
Data are presented as mean (95% CI). value by paired t-test ().
